For a better experience, click the Compatibility Mode icon above to turn off Compatibility Mode, which is only for viewing older websites.

XiaoHuang

Xiao Huang

Assistant Professor
School of Biomedical Engineering, Science and Health Systems

Email: xh324@drexel.edu
Website: Precision Immune Engineering Laboratory

Bio

Xiao Huang received his BS degree in Nanjing Agricultural University in Biological Sciences and his MS degree in Biochemical Engineering in East China University of Science and Technology in Shanghai China. He then received his PhD degree in Chemistry and Materials at UC Santa Barbara in 2016. There he worked on the spatial control of gene regulation in human embryonic stem cells through light-responsive nanomaterials. He went on to conduct his postdoctoral research at UC San Francisco, working at the interface between biomaterials and immune engineering. One highlight from his work is the development of a robust chemistry to surface-functionalize biocompatible materials with exquisite precision for applications in immune modulation. To date, he has published first-authored papers in Nat. Nanotechnol., Adv. Mater., ACS Nano, Biomaterials, Nano letters, etc., is a co-inventor on 2 pending patents, and has received fellowships from UCSF-PBBR, Li Foundation, and CIRM. He also received the 2022 BWF BioInterfaces Rising Star Award. His future research interest is to develop innovative engineering platforms and analytical methods to advance understanding and control of immunotherapies.

Education

  • PhD in Chemistry and Materials, University of California Santa Barbara, 2016
  • MS Biochemical Engineering, East China University of Science and Technology, 2011
  • BS Biological Sciences, Nanjing Agricultural University, 2008

Awards and Honors
  • American Association of Immunologists Annual Meeting Abstract Award, 2020 - 2021
  • UCSF The Program for Breakthrough Biomedical Research Fellowship, 2017 - 2018
  • Li Foundation Fellowship, 2017 - 2019

Research Interests

Develop innovative engineering platforms and analytical methods to advance understanding and control of immunotherapies.